Literature DB >> 25061579

Short-course hypofractionated radiochemotherapy for unresectable locally advanced cancer of the base of tongue: palliation only? A case report and short review of the literature.

Maria-Aggeliki Kalogeridi1, Vassilios Kouloulias2, Anna Zygogianni3, George Kyrgias3.   

Abstract

We present a case of unresectable cancer of the base of tongue treated with hypofractionated 3D conformal radiotherapy and concomitant chemotherapy. Based on the excellent tumour response in this radiotherapy regimen and international experience in short course treatments we shortly reviewed, we propose that this therapeutic approach could be considered in a curative setting for patients unsuitable for the a standard long course radiochemotherapy schedule.

Entities:  

Keywords:  Base of tongue neoplasms; Chemoradiotherapy; Head neck neoplasms; Hypofractionated radiotherapy

Year:  2014        PMID: 25061579      PMCID: PMC4104226          DOI: 10.3857/roj.2014.32.2.99

Source DB:  PubMed          Journal:  Radiat Oncol J        ISSN: 2234-1900


  4 in total

1.  The role of split-course hypofractionated palliative radiotherapy in head and neck cancer.

Authors:  K N Kancherla; D C Oksuz; R J D Prestwich; C Fosker; K E Dyker; C C Coyle; M Sen
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-10-08       Impact factor: 4.126

2.  Hypofractionated palliative radiotherapy for advanced head and neck cancer: the IHF2SQ regimen.

Authors:  Laurie Monnier; Emmanuel Touboul; Catherine Durdux; Philippe Lang; Jean Lacau St Guily; Florence Huguet
Journal:  Head Neck       Date:  2013-01-29       Impact factor: 3.147

3.  Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study.

Authors:  Bidhu K Mohanti; Hombaiah Umapathy; Sudhir Bahadur; Alok Thakar; Sushmita Pathy
Journal:  Radiother Oncol       Date:  2004-06       Impact factor: 6.280

4.  Hypofractionated, palliative radiotherapy for advanced head and neck cancer.

Authors:  Jai Prakash Agarwal; Bhushan Nemade; Vedang Murthy; Sarbani Ghosh-Laskar; Ashwini Budrukkar; Tejpal Gupta; Anil D'Cruz; Prathamesh Pai; Pankaj Chaturvedi; Ketayun Dinshaw
Journal:  Radiother Oncol       Date:  2008-07-21       Impact factor: 6.280

  4 in total
  1 in total

1.  Proton Radiotherapy for Recurrent or Metastatic Head and Neck Cancers with Palliative Quad Shot.

Authors:  Jennifer Ma; Benjamin H Lok; Jingfeng Zong; Stanley I Gutiontov; Xin Cai; Andrew C Bell; Marina Shcherba; Han Xiao; Eric J Sherman; Chiaojung Jillian Tsai; Nadeem Riaz; Sean M McBride; Oren Cahlon; Nancy Y Lee
Journal:  Int J Part Ther       Date:  2018
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.